Campaign targets Abercrombie "spraying"
This article was originally published in The Rose Sheet
Executive Summary
"Parents, teenagers, health-care professionals, faith organizations, environmental health and justice groups" representing 1.5 million people in total sign onto Campaign for Safe Cosmetics letter to Mike Jeffries, CEO of apparel and lifestyle brand Abercrombie & Fitch, asking company to discontinue its practice of spraying fragrance via air sprayers in its stores, which poses potential health risks to workers and shoppers in the more than 300 Abercrombie stores nationwide, group says. Its concerns are based on data showing "a significant percentage of the population reports adverse effects to fragrance products" and movement from U.S. Centers for Disease Control, other government offices and universities to implement fragrance-free policies. Citing Campaign's "Not So Sexy" report released in May, the alliance takes a leery view on Abercrombie's flagship scent Fierce, which it claims contains 11 "hidden" chemicals not listed on labeling, eight sensitizing chemicals associated with allergic reactions and diethyl phthalate, linked to reproductive toxicity in infants and adult males. Over the longer term, group urges the retailer to remove "hazardous chemicals" from its colognes and personal-care products. In addition to the letter, the Campaign has launched "a social media blitz" on Twitter and Facebook "demanding that A&F stop spraying.
You may also be interested in...
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.